Recent clinical trials demonstrate that obesity medications like Wegovy may be effective for children as young as six years old. Participants in global studies experienced significant weight reduction, averaging nearly 42 pounds. This development raises important questions about early intervention strategies for childhood obesity, potential long-term health benefits, and safety considerations for young patients. Medical professionals are evaluating whether pharmaceutical approaches should complement lifestyle modifications in pediatric weight management programs.

Summary auto-generated by AI from the original publisher's content. Editorial standards.